Overview
NICHD will reissue a notice of funding opportunity (NOFO) to solicit applications for research to advance the diagnosis, prevention, treatment, and amelioration of IDDs through the IDDRCs. Each IDDRC will promote highly collaborative, basic, translational, and clinical research in IDD.
NICHD encourages collaborative investigations combining expertise in translational science, biomarker assessment, outcome measure development, tool validation, bioinformatics, and therapeutic development. In addition, the institute expects proposals to establish meaningful partnerships with the community, including persons with lived experience of disabilities.
Please review NOT-HD-24-023: Notice of Intent to Publish a Funding Opportunity Announcement for IDDRCs 2025 (P50 Clinical Trial Optional) for more information.
FAQs
What components will be required for the IDDRCs in fiscal year (FY) 2025?
Each IDDRC application for the FY2025 competition is expected to include the following components:
- Administrative Core
- Clinical Translational Core
- One to two additional core(s)
- Two to three specific research projects designed to improve the translation of existing knowledge or strategies for the prevention, treatment, and/or amelioration of IDD
- Outside research projects funded by federal, state, and private sources
- Plans for outreach, engagement, and dissemination to the community
- Plan for Enhancing Diverse Perspectives (PEDP)
Are their requirements for community outreach and engagement?
Proposals should include plans for outreach and dissemination along with a specific strategy for community engagement as part of the Administrative Core.
How many projects does each proposal need to include?
Each IDDRC must propose at least two specific research projects but no more than three.